Kwality Pharmaceuticals Ltd concludes regulatory audit for Zimbabwe

Kwality Pharmaceuticals Ltd. (KPL) has successfully concluded a regulatory audit for Zimbabwe across its General, Beta-Lactam, Cephalosporin and Oncology units, with no critical observations. This marks yet another milestone in our series of successful audits over the past year.

This achievement underscores our unwavering commitment to quality, regulatory compliance, and operational excellence. It also strengthens our footprint in the ZAZIBONA region, paving the way for expansion and new strategic partnerships across Southern Africa.

Shares of Kwality Pharmaceuticals Ltd was last trading in BSE at Rs. 682.05 as compared to the previous close of Rs. 719.45. The total number of shares traded during the day was 30886 in over 1615 trades.

The stock hit an intraday high of Rs. 728.95 and intraday low of 666.00. The net turnover during the day was Rs. 21265395.00.

Source : Equity Bulls

Keywords

KwalityPharmaceuticals INE552U01010 RegulatoryAudit Zimbabwe